BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36575439)

  • 1. High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma.
    Yang Y; Ye F; Xia T; Wang Q; Du J
    BMC Cancer; 2022 Dec; 22(1):1355. PubMed ID: 36575439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
    Cheng L; Mi J; Zhang J; Huang H; Mo Z
    Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
    Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
    Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
    Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
    Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Tian J; Cheng C; Gao J; Fu G; Xu Z; Chen X; Wu Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
    Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
    Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment.
    Jiang Z; Zhang W; Zeng Z; Tang D; Li C; Cai W; Chen Y; Li Y; Jin Q; Zhang X; Yin L; Liu X; Xu Y; Dai Y
    Front Immunol; 2022; 13():926461. PubMed ID: 36311770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion.
    Fan X; Liu B; Wang Z; He D
    Aging (Albany NY); 2021 Mar; 13(6):8541-8562. PubMed ID: 33714201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
    Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
    Front Genet; 2023; 14():1109991. PubMed ID: 36992705
    [No Abstract]   [Full Text] [Related]  

  • 10. Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration.
    Zhang C; Huang G; Yang J; Jiang Y; Huang R; Ye Z; Huang Y; Hu H; Xi X
    Front Immunol; 2023; 14():1197011. PubMed ID: 37383233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
    Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
    [No Abstract]   [Full Text] [Related]  

  • 12. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
    Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
    Front Genet; 2022; 13():978840. PubMed ID: 36186442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the role of MICAL1 in pan-cancer using integrated bioinformatics and experimental approaches.
    Li C; Xiao Y; Kong J; Lai C; Chen Z; Li Z; Xie W
    Cell Adh Migr; 2024 Dec; 18(1):1-17. PubMed ID: 38555517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.
    Yang Z; Jiang Y; Wang L; Yu B; Cai H; Fan J; Zhang M
    BMC Med Genomics; 2024 Feb; 17(1):60. PubMed ID: 38383432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
    Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
    Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Reduced PTGER3 Expression with Prognosis and Immune Infiltration in Clear Cell Renal Carcinoma.
    Yang K; Hu B; Zhu G; Yuan D; Wang W; Su H; Liu H; Zhu J
    Arch Esp Urol; 2023 Jun; 76(4):270-282. PubMed ID: 37455526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
    Jiang H; Chen H; Wan P; Chen N
    Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.
    Cao H; Zhang J; Wang W
    Technol Cancer Res Treat; 2020; 19():1533033820936682. PubMed ID: 32583730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
    Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration.
    Tang YF; Qiao B; Huang YB; Wang M
    Front Mol Biosci; 2023; 10():1202524. PubMed ID: 37795220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.